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Glucose-sensing neurons in the brainstem partici-
pate in the regulation of energy homeostasis but
have been poorly characterized because of the lack
of specific markers to identify them. Here we show
that GLUT2-expressing neurons of the nucleus of
the tractus solitarius form a distinct population of
hypoglycemia-activated neurons. Their response to
low glucose is mediated by reduced intracellular
glucose metabolism, increased AMP-activated pro-
tein kinase activity, and closure of leak K+ channels.
These are GABAergic neurons that send projections
to the vagal motor nucleus. Light-induced stimula-
tion of channelrhodospin-expressing GLUT2 neu-
rons in vivo led to increased parasympathetic nerve
firing and glucagon secretion. Thus GLUT2 neurons
of the nucleus tractus solitarius link hypoglycemia
detection to counterregulatory response. These re-
sults may help identify the cause of hypoglycemia-
associated autonomic failure, a major threat in the
insulin treatment of diabetes.
INTRODUCTION
Feeding, energy expenditure, and glucose homeostasis are pro-
cesses that are regulated by many signals reflecting the meta-
bolic status of the organism. Nutrients, including glucose, lipids,
and amino acids, play a particularly important role in orches-
trating these responses by directly controlling the secretion of
hormones, such as insulin and glucagon, and by modulating
the activity of the autonomic nervous system to coordinate the
adaptation of peripheral organs to changes in energy meta-
bolism (Schwartz et al., 2000; Thorens, 2012).
Glucose-sensing neurons have been identified and classified
in two major categories, glucose excited (GE) and glucose in-
hibited (GI), depending on the effect of extracellular glucose on
their firing activity (Routh, 2002). There is evidence for a large
diversity in the mechanisms of neuronal glucose sensing andCefor their wide topographical distribution (Thorens, 2012). It is
established that the hypothalamus and brainstem are important
centers that integrate nutrient, hormonal, and nervous signals
controlling energy metabolism. Evidence has been provided
that neuropeptide Y (NPY) and proopiomelanocortin (POMC)
neurons in arcuate nucleus (AN), melanin-concentrating hor-
mone (MCH) and orexin neurons of the lateral hypothalamus
(LH), as well as a large number of neurons from the ventromedial
hypothalamus (VMH) are glucose responsive and may control
adaptive responses to hypo- or hyperglycemia (Gonza`lez et al.,
2009; Kang et al., 2004; Parton et al., 2007). In the brainstem,
the dorsal vagal complex (DVC), which consists of the area post-
rema (AP), the nucleus of the tractus solitarius (NTS), and the
dorsal motor nucleus of the vagus (DMNX), also contains GE
and GI neurons (Balfour et al., 2006; Balfour and Trapp, 2007).
These neurons are involved in various glucoregulatory functions,
including the stimulation of feeding and glucagon secretion in
response to hypoglycemia and the increase of insulin secretion
in response to hyperglycemia (Marty et al., 2005, 2007; Ritter
et al., 2000). They also control gastric motility (Ferreira et al.,
2001; Grill and Hayes, 2012). Although there is abundant evi-
dence for the presence of glucose-sensing neurons in the brain-
stem, the lack of specific markers hampers a clear identification
of these cells and any further characterization of their molecular
mechanisms of glucose detection, and of the neuronal circuits in
which they are integrated.
In previous studies, we reported that expression of the
glucose transporter GLUT2 in the brain is required for several
glucoregulatory responses, including glucagon secretion (Marty
et al., 2005), feeding (Bady et al., 2006), and thermoregulation
(Mounien et al., 2010). Using a genetic reporter system, we
showed that GLUT2-expressing neurons were scattered in
different hypothalamic nuclei, including the LH, VMH, paraven-
tricular hypothalamus, and the zona incerta (Mounien et al.,
2010). In the AN, GLUT2-expressing nerve terminals were
found in contact with NPY and POMC neurons, which did not ex-
press themselves this gene. GLUT2 neurons were also found in
the brainstem, in particular in the DVC. In this structure, neuro-
glucopenia activated c-fos expression in GLUT2 cells, suggest-
ing that they areGI neurons (Mounien et al., 2010).More recently,
we showed that Glut2 inactivation in the nervous system
(NG2KO mice) led to suppressed regulation by glucose of thell Metabolism 19, 527–538, March 4, 2014 ª2014 Elsevier Inc. 527
Figure 1. Glucose Response of GLUT2 Neurons in NTS
(A) Confocal images of GLUT2 neurons in NTS showing a cluster of tdTomato-labeled neurons (left) and a single patched neuron superimposed with the
corresponding infrared DIC image in an acute mouse brainstem slice (right). Recording pipette is delineated by white dashed lines.
(B) Voltage trace from a GLUT2 neuron showing a typical accommodating spike train induced by depolarizing current injection.
(C) Agarose gel showing RT-PCR amplification products of Glut2 and control gene b-actin from the cytosol of single tdTomato-positive cells aspirated with the
recording pipette. Right lane, molecular weights marker.
(legend continued on next page)
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impaired proliferation of beta cells during the weaning period,
reduced adult beta cell mass, suppression of first-phase insulin
secretion, and progressive development of glucose intolerance.
When NG2KOmice were fed a high-fat diet, glucose intolerance
developed faster and glucagon secretion became deregulated
(Tarussio et al., 2014). Thus, GLUT2-expressing cells in the ner-
vous system are involved in the control by glucose of the auto-
nomic nervous activity, which controls endocrine pancreas
development and function. However, the specific role of
GLUT2 neuron subpopulations present in different hypothalamic
and brainstem nuclei is not yet defined.
Here, we report the electrophysiological properties of GLUT2
neurons of the NTS, which form a homogeneous population of
GI neurons mechanistically dependent on intracellular glucose
metabolism, AMP kinase, and activation of a leak K+ current.
Furthermore, we find that these neurons are GABAergic inter-
neurons sending projections to the DMNX. We show that when
activated by optogenetic tools, they increase parasympathetic
activity and stimulate glucagon secretion, thus defining a
neuronal circuit linking hypoglycemia detection to counterregu-
latory response.
RESULTS
GLUT2 Cells Are Glucose-Sensing Neurons Excited by
Low Glucose Levels
To identify GLUT2-expressing cells in brainstem, we crossed
Glut2-Cre mice (Mounien et al., 2010) with a Rosa26tdTomato
reporter line (Madisen et al., 2010). We observed clusters of
tdTomato-positive (tdT+) cells in the NTS of resulting animals
(Figure 1A). These cells were more frequently found in the caudal
and dorsal aspects of the NTS, in agreement with existing re-
ports on the anatomical localization of GLUT2 cells in the brain-
stem (Arluison et al., 2004). They appeared asmultipolar neurons
with extensive projections inside andoutside theNTS (Figure 1A).
We performed whole-cell patch-clamp recordings in acute
brainstem slices to analyze their electrophysiological properties
(Figure 1A and Table S1 available online). tdT+ cells were not
spontaneously active; however, they fired accommodating
spike trains when stimulated by depolarizing current injection
(Figure 1B). Single-cell RT-PCR (scRT-PCR) amplification per-
formed on cytosols collected at the end of electrophysiological
recordings detected expression of Glut2 in 67% of tdT+ cells
(Figure 1C). The failure to detectGlut2 in every cell was attributed
to the low levels of expression of this gene (Arluison et al., 2004)
and the low sensitivity of scRT-PCR. Because of this and the
absence of GLUT2 detection in all tested tdT cells (data not(D) Left: Vm and Rinput plotted over time in 30 s bins during changes in extracellular
representative voltage traces at 5mM (black) to 0.5mM (blue) glucose showing the
to monitor Rinput. See also Figure S1.
(E) Glucose effect on Vm and Rinput in the presence (n = 13) or absence (n = 12) o
(F) Left: representative voltage traces at 5mM (black) and 0.5mM (blue) glucose sh
Right: FI curves (n = 10) obtained at 5 mM (black) and 0.5 mM glucose (blue).
(G) Glucose effect on rheobase (n = 12) and FI curve gain (n = 10) in the presenc
(H) Changes in membrane potential, input resistance, rheobase, and FI curve
exponential decay fits to the data.
Error bars represent SEM. n.s., not significant; **p < 0.01; ***p < 0.001.
Ceshown), we concluded that the tdTomato reporter system selec-
tively labeled Glut2-expressing cells.
We assessed whether GLUT2 neurons sensed extracellular
glucose level by recording their electrical properties while
changing glucose concentration in the superfusion buffer.
Switching from 5 to 0.5 mM glucose produced a reversible
increase in resting membrane potential (Vm) of 6.7 ± 1.0 mV
(p < 2 3 105, n = 13) and in input resistance (Rinput) of 451 ±
75 MU (p < 6 3 105, n = 13) (Figures 1D and 1E). This glucose
response pattern was observed consistently in all the tdT+ cells
we recorded (n = 25). By contrast, neighboring tdT neurons
were unresponsive to a similar change in glucose concentration
(DVm =0.2 ± 0.4 mV, p > 0.53, n = 5; DRinput =129 ± 133 MU,
p > 0.38, n = 5), indicating that this effect is specific to GLUT2
cells (Figures S1A and S1B). The response of tdT+ neurons to
glucose was not altered when experiments were repeated in
the presence of inhibitors of synaptic transmission (DVm =
5.5 ± 1.0 mV, p < 0.0002, n = 12; DRinput = 395 ± 79 MU, p <
0.0004, n = 12), demonstrating a cell-autonomous effect (Figures
1D and 1E).
To test the impact of glucose-dependent variations in resting
membrane properties on cell excitability, we injected depolariz-
ing current steps and plotted the observed firing rates as a func-
tion of injected current intensity (FI curve). Switching from 5 mM
to 0.5 mM glucose increased the firing frequency for the same
amount of current injected (Figure 1F), leading to an increase in
the slope of the FI curve (FI gain) of 0.082 ± 0.020 Hz/pA (p <
0.0025, n = 10; Figures 1F and 1G). This increase in excitability
was confirmed by a decrease in the minimal amount of current
required to trigger action potentials (rheobase) of 30.8 ± 9.4 pA
(p < 0.0073, n = 12; Figure 1G). The absence of any glucose
effect on single action potential and spike train properties (Table
S2) indicated that changes in excitability were only due to alter-
ations of passive membrane properties. Experiments performed
in the presence of synaptic blockers yielded changes in FI gain
(DFI gain = 0.141 ± 0.038 Hz/pA, p < 0.0047, n = 10) and rheo-
base (DRheobase = 16.4 ± 5.7 pA, p < 0.016, n = 12) similar
to those without inhibitors (Figure 1G), confirming that lowering
glucose increased cell excitability independently from neuronal
network activity.
We further determined that passive membrane properties and
indices of cell excitability (FI gain and rheobase) changed mono-
tonically with intermediate glucose concentrations (Figure 1H).
Thus, GLUT2 neurons reliably detect glucose changes for typical
concentrations found in brain extracellular medium (Dunn-
Meynell et al., 2009; Silver and Erecinska, 1994).
To exclude that the whole-cell patch-clamp approach used
above could affect cell responses by altering the concentrationglucose concentration, in the presence or absence of synaptic inhibitors. Right:
response to the hyperpolarizing current steps (sketched below traces) applied
f synaptic inhibitors.
owing action potential trains elicited by a depolarizing current injection (below).
e or absence of synaptic inhibitors.
gain as a function of glucose concentration (n = 5). Dashed lines are mono-
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Figure 2. Biophysical Mechanisms of the Glucose-Inhibited Effect
(A) Left: current-voltage plot showing a reversible inward shift when switching from 5 to 0.5 mM glucose. Middle: the current-voltage plot of net glucose-induced
current (n = 12) shows an outward rectification fitted by the GHK current equation (red dashed line). Right: time course of net glucose-induced current in response
to voltage steps (below). See also Figure S2.
(legend continued on next page)
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performed cell-attached recordings to monitor cell excitability
without interfering with cell content. Action potential firing
increased by 2.3-fold (p < 0.0039, n = 6) when glucose concen-
trationwas lowered from 5 to 0.5mM, in the presence of synaptic
blockers (Figures S1C and S1D), ruling out any significant effect
of the recording procedure on the response of GLUT2 neurons to
glucose.
Leak Potassium Channels Drive the Glucose Response
of GLUT2 Neurons
We further investigated ionic conductances underlying glucose-
induced inhibition in GLUT2 neurons. The cell depolarization
paired with Rinput increase under lowered glucose (Figures 1D
and 1E), suggested a mechanism involving the closure of
a conductance for hyperpolarizing ions. Under recording
conditions used in these experiments, calculated equilibrium
potential for main ion species present indicated that only K+
(EK = 101 mV) and Cl (ECl = 75 mV) currents would reverse
at more hyperpolarized values than the resting membrane po-
tential. We therefore acquired current voltage (IV) relationships
at different glucose concentrations. Switching glucose from
5 mM to 0.5 mM resulted in a reversible decrease in the IV curve
slope (Figure 2A), corresponding to an increase of 323 ± 68MU in
Rinput (p < 6.4 3 10
4, n = 12), in agreement with the change
measured by periodic current pulse injection during continuous
voltage recordings. In addition, IV curves showed that whole-
cell currents varied monotonically with glucose concentration,
with the same nonlinear dependency as that of cell properties
measured previously (Figure S2A). Net glucose-induced current
was calculated as the difference between current values
measured at 5 mM and 0.5 mM. IV curve of net glucose current
showed a reversal potential of 95.5 ± 2.0 mV, indicating a
conductance selective for K+ (Figure 2A). Moreover, this IV curve
had an outward rectifying trend well described by the Goldman-
Hodgkin-Katz (GHK) current equation (Figure 2A), which pointed
to a leak K+ channel (Burdakov et al., 2006). The kinetics of net
glucose-induced currents during voltage steps, consisting of a
fast activation and an absence of decay over time (Figure 2A),
are further attributes in favor of a leak K+ conductance (Burdakov
et al., 2006). The shape of net glucose current IV curve clearly
excluded a voltage-gated K+ channel or an inwardly rectifying
K+ channel. Calcium-dependent K+ channels were unlikely to
contribute to glucose effect, since no changes in AHP or spike
frequency adaptation were observed (Table S2).
To confirm the nature of the conductance responsible for the
glucose effect, we performed recordings using a pipette solution
with elevated Cl in order to shift the calculated equilibrium
potential of this ion to a value more depolarized than resting
membrane potential (ECl = 0 mV). In this condition, if Cl
 chan-
nels were involved, their opening at 5 mM glucose would lead
to an excitatory effect, while decreasing glucose would result(B) Voltage trace recorded with high Cl intracellular solution, showing a depolar
(C) Current trace recorded at 70 mV with high Cl intracellular solution and in t
(D) Glucose effect on Vm (n = 11), Rinput (n = 11), rheobase (n = 9), and FI curve g
(E) Voltage trace showing the depolarization induced by quinine and its blocking
(F) Quinine effect on Vm and Rinput (n = 6) mimics that of low glucose and impairs
Error bars represent SEM. n.s., not significant; *p < 0.05; ***p < 0.001.
Cein inhibition. Instead, switching from 5 mM to 0.5 mM glucose
produced a depolarization (DVm = 9.8 ± 1.3 mV, p < 1.9 3
105, n = 11; Figures 2B and 2D) and an increase in cell
excitability (DFI gain = 0.132 ± 0.041 Hz/pA, p < 0.0047, n = 9;
DRheobase = 51.9 ± 17.3 pA, p < 0.016, n = 9; Figure 2D)
similar to those obtained with low pipette Cl, supporting
the sole implication of K+ channels. Continuous recording of
glucose-induced current with high intrapipette Cl in the pres-
ence of tetrodotoxin unveiled an outward current of 18.6 ±
4.5 pA consistent with the closure of a K+ conductance (Fig-
ure 2C). In agreement with the implication of leak K+ channels,
net glucose-induced current displayed an outward rectification
and reversed at a value similar to that with low Cl intracellular
solution (Erev = 103.8 ± 3.6 mV, p > 0.066; Figure S2B).
We also pharmacologically probed the ionic mechanism of
glucose effect. Bath application of leak K+ channel blocker qui-
nine (200 mM) produced an increase in Vm (DVm = 12.4 ±
2.2 mV, p < 0.003, n = 6) and Rinput (DRinput = 506 ± 172 MU,
p < 0.033, n = 6; Figures 2E and 2F) and an inward shift of the
IV curve (Figure S2C) indicative of the closure of a hyperpolariz-
ing resting conductance. The quinine-inhibited current, obtained
by subtracting currents before and after quinine application, was
outward rectifying, reversed at 97.5 ± 2.8 mV, and fitted by the
GHK current equation (r2 = 0.98) (Figure S2C), confirming the
expression of functional leak K+ channels by NTS GLUT2
neurons at rest. Furthermore, quinine prevented electrophysio-
logical changes induced by lowering glucose concentration
(DVm = 1.5 ± 1.2 mV, p < 0.27; DRinput = 72 ± 36 MU, p < 0.11,
n = 6; Figures 2E and 2F), showing that leak K+ channels are
required for the glucose response.
GlucoseMetabolism Is Required for Glucose Sensing by
GLUT2 Neurons
We next tested if changes in GLUT2 neuron excitability de-
pended on glucosemetabolism. Superfusion of themetabolic in-
hibitor 2-deoxyglucose (2-DG, 10 mM) in the presence of 5 mM
glucose induced an increase in Vm (DVm = 6.8 ± 1.1 mV, p <
0.003, n = 5) and Rinput (DRinput = 263 ± 76 MU, p < 0.026,
n = 5; Figures 3A and 3B) that mimicked the changes in mem-
brane properties observed when lowering extracellular glucose,
indicating that integrity of glucose metabolic pathways is
important for the effect of glucose on these neurons. We then
tested whether superfusion of glucokinase competitive inhibitor
D-glucosamine in the presence of high glucose would mimic the
effect of glucoprivation on GLUT2 neurons. D-glucosamine
(10 mM) produced changes on resting membrane properties
similar to those of glucose depletion (DVm = 5.8 ± 1.0 mV, p <
0.0014, n = 7; DRinput = 182 3 53 MU, p < 0.014, n = 7; Figures
3C and 3D), showing that the glucose-induced inhibition of
GLUT2 neurons depends on intracellular processing of glucose.
Studies on glucose-sensing mechanisms in other brain areas
have reported direct effects of glucose on cell membraneizing response to low glucose.
he presence of TTX, showing a glucose-induced outward K+ current.
ain (n = 9) with high Cl intracellular solution.
effect on the response to changes in glucose concentration.
glucose sensing.
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Figure 3. Glucose Effect Is Mediated by Cell
Metabolism
(A) Voltage trace showing a partly reversible depolarizing
effect of 2-DG in the presence of 5 mM glucose.
(B) The 2-DG effect on Vm and Rinput (n = 5) mimics that of
low glucose.
(C) Voltage trace showing a reversible depolarizing effect
of D-glucosamine in the presence of 5 mM glucose.
(D) The D-glucosamine effect on Vm and Rinput (n = 7)
mimics that of low glucose.
(E) Voltage trace showing the response to extracellular
glucose when the cell was recorded with a glucose-
containing intracellular solution (upper trace). In the
same cell, adding D-glucosamine to the bath induced a
depolarization and an increase in Rinput (lower trace).
(F) Intracellular glucose infusion blunts Vm and Rinput
responses to glucoprivation, an effect reversed by
D-glucosamine (n = 7).
Error bars represent SEM. n.s., not significant; *p < 0.05;
**p < 0.01.
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2009; O’Malley et al., 2006). To investigate whether glucose
had a similar action on GLUT2 neurons in NTS, we performed
whole-cell recordings with glucose present in the pipette.
In this condition, where intracellular glucose metabolism is
rendered independent from extracellular supply, responses to
changes in extracellular glucose were abolished (DVm = 0.5 ±
0.4 mV, p > 0.22, n = 7; DRinput = 11 ± 19 MU, p > 0.59,
n = 7; Figures 3E and 3F). Nevertheless, adding D-glucosamine
to these neurons still produced a glucoprivic pattern of mem-
brane response (DVm = 5.4 ± 0.9 mV, p < 0.0014, n = 6; DRinput =
407 ± 123 MU, p < 0.022; n = 6; Figures 3E and 3F), indicating
that the presence of glucose in the pipette did not result in a
nonspecific blunting of cell responsiveness. These experiments
confirmed that the glucose-sensing mechanism requires cellular
glucose uptake and catabolism.
Glucose Response Is Mediated by AMPK
We hypothesized, in agreement with former results, that glucose
effect on GLUT2 neurons is mediated by changes in cellular
energy levels. Inducing a cellular ATP depletion by the superfu-
sion on mitochondrial ATPase inhibitor oligomycin (12 mM)
resulted in an increase in Vm (DVm = 7.2 ± 1.7 mV, p < 0.006,
n = 7) and Rinput (DRinput = 474 ± 102.3 MU, p < 0.004, n = 7;
Figures 4A and 4B) similar to the changes in membrane proper-
ties produced by low glucose levels, suggesting that a decrease
of ATP supply is the main signal driving the response to
glucoprivation.
Because AMP-activated protein kinase (AMPK) is a key sensor
of cellular energy levels activated by ATP depletion, and it is
known to play an important role in the central regulation of
energy homeostasis (Lage et al., 2008), we looked at its
implication in the response of GLUT2 neurons to glucose. Bath
application of AMPK activator AICAR (500 mM) produced effects
similar to those of glucoprivation (DVm = 8.5 ± 1.4 mV, p < 0.001;
DRinput = 411 ± 129 MU, p < 0.020, n = 7; Figures 4C and 4D).
In addition, AMPK inhibitor Compound C (150 mM) reversed
the response to low glucose (DVm = 5.1 ± 1.2 mV, p < 0.006;
DRinput = 396 ± 92 MU, p < 0.005, n = 7) and blocked
glucose-dependent changes (DVm = 0.6 ± 0.5 mV, p < 0.3;
DRinput = 27 ± 57 MU, p < 0.7, n = 7; Figures 4E and 4F). Finally,
we detected the expression of AMPK by immunohistochemistry
in 67.9% of NTS GLUT2 neurons (n = 109; Figure 4G). Together,
these results demonstrate that AMPKmediates glucose sensing
in NTS GLUT2 neurons.
NTS GLUT2 Neurons Are Inhibitory Cells Projecting
to DMNX
We then performed immunohistochemistry to determine the
nature of the GLUT2-expressing cells. We observed that
GAD67, a marker of GABAergic inhibitory neurons, was ex-
pressed in 80% of tdT+ cells (n = 110; Figure 5A). GLUT2 neu-
rons also frequently expressed parvalbumin (PV), a marker found
in GABAergic cell subpopulations (Figure 5B). GABAergic pro-
jections from NTS were previously shown to drive DMNX re-
sponses to glycemic changes (Ferreira et al., 2001). To check
whether NTS GLUT2 neurons project to DMNX, we filled them
with biocytin during whole-cell recording and postprocessed
slices to reveal axonal projections of recorded cells with confocalCemicroscopy. Coimmunostaining for choline acetyltransferase
(ChAT) was used to localize DMNX cholinergic cells. Biocytin-
filled axons from some of the NTS tdTomato-positive neurons
we recorded could be followed down to DMNX (Figure 5C),
with axons showing enlargements reminiscent of axonal boutons
in this area (Figure 5C). This suggests that NTS GLUT2 neurons
provide GABAergic input to DMNX.
NTS GLUT2 Neurons Activate the Vagus and Glucagon
Secretion In Vivo
We sought to determine the role of GLUT2 neurons in vivo.
Because GLUT2 neurons respond to low glucose levels and
project to vagalmotor neurons, we reasoned that theymay affect
vagal output and drive the counterregulatory response to hypo-
glycemia. To test this hypothesis, we used an optogenetics
approach. We crossed Glut2-Cre mice with a Rosa26ChR2-
YFP reporter line (Madisen et al., 2012) to express channelrho-
dopsin (ChR2) in GLUT2 neurons. We recorded these cells by
whole-cell patch clamp in acute NTS slices to check the effi-
ciency of ChR2 expression (Figure 6A). Blue light illumination
(473 nm) induced a reversible photocurrent and action-potential
firing (Figures 6B and S3A). When using pulsed (10 ms) illumina-
tion, the frequency of both photocurrents and action potentials
increased with that of light pulses (Figures 6C, S3B, and S3C).
In vivo optogenetic stimulations were performed in anesthetized
micewhile vagal activity was recorded. An optical fiber was posi-
tioned with a stereotaxic micromanipulator at the dorsal face of
the NTS to deliver pulses of blue light (Figure 6D). Light stimula-
tion induced a rapid increase of vagal firing rate in ChR2-
expressing animals, but not in Cre/ChR2+ littermates (p <
0.0001, two-way ANOVA, n = 6; Figure 6E). Blood glucagon
levels, measured shortly after the end of the stimulation, were
significantly higher in ChR2-expressing animals as compared
to Cre/ChR2+ controls (glucagon = 105.0 ± 31.7, n = 7, versus
326.5 ± 66.1 pg/ml, n = 6; p < 0.009; Figure 6F). No differences in
basal glucagonemia existed between the twogroups (glucagon=
135.0 ± 51.5, n = 11, versus 143.4 ± 21.6 pg/ml, n = 10; p < 0.9;
Figure 6F). These data provide evidence for a role for NTSGLUT2
neurons in the control of the parasympathetic regulation of
glucagon secretion.
DISCUSSION
Our results establish that expression of the glucose transporter
isoform GLUT2 identifies a homogenous glucose-sensing
neuronal subpopulation in the nucleus tractus solitarius. These
GLUT2 neurons are glucose-inhibited cells whose response
depends on intracellular glucose metabolism-driven changes in
permeability of background potassium channels; they are
GABAergic inhibitory neurons. Optogenetic activation of these
NTS GLUT2 neurons activates parasympathetic nerve firing
and glucagon secretion, suggesting that they play an important
role in the counterregulatory response to hypoglycemia.
Glucose-sensing neurons have been identified in several
brain areas involved in the control of energy homeostasis and
related behaviors (Thorens, 2012). In the dorsal vagal complex,
about 20% of neurons respond to glucose with either a GE or a
GI pattern (Balfour et al., 2006; Yettefti et al., 1997). GI neurons
in this structure use a variety of molecular mechanisms toll Metabolism 19, 527–538, March 4, 2014 ª2014 Elsevier Inc. 533
Figure 4. Glucose Effect Depends on AMP Kinase
Activation
(A) Voltage trace showing a partly reversible depolarizing
effect of oligomycin in the presence of 5 mM glucose.
(B) The oligomycin effect on Vm and Rinput (n = 7) mimics that of
low glucose.
(C) Voltage trace showing a depolarizing effect of AICAR in the
presence of 5 mM glucose.
(D) The AICAR effect on Vm and Rinput (n = 7) mimics that of low
glucose.
(E) Voltage trace showing the blocking effect of Compound C
on the depolarization induced by low glucose.
(F) Compound C inhibits Vm and Rinput (n = 7) responses to low
glucose.
(G) Confocal images of brainstem sections showing the
colocalization of AMPK subunit pAMPKa immunostaining
(green), with tdTomato labeling of GLUT2 neurons (red,
arrows).
Error bars represent SEM. n.s., not significant; *p < 0.05;
**p < 0.01.
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Figure 5. NTS GLUT2 Neurons Are
GABAergic Cells Projecting to DMNX
(A and B) Confocal images of brainstem sections
showing the colocalization of GABAergic neuron
marker GAD67 (A) and inhibitory neuron marker
parvalbumin (PV) (B) immunostainings (green),
with tdTomato labeling of GLUT2 neurons (red,
arrows).
(C) Left: projection image of a confocal stack of a
tdTomato-positive neuron (red, star) patched in
NTS with a pipette solution containing biocytin.
Neutravidin labeling (green) reveals the path of the
biocytin-filled axon (arrowheads) toward DMNX,
which contains ChAT immunopositive neurons
(purple). Right: 3D rendering of a high-resolution
image of the area delineated with a white dashed
line in the left panel, showing axonal boutons
in DMNX.
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(Balfour and Trapp, 2007), indicating that they form a diverse
population of glucose-responsive cells. Their precise topo-
graphical and functional characterization is, however, difficult
to assess because of the absence of specific markers allowing
their identification. In this study, we found GLUT2 to consis-
tently single out a specific population of GI neurons in NTS.
This glucose transporter isoform was first described for its
role in glucose sensing in pancreatic beta cells leading to insu-
lin secretion. Previous data suggested that it might hold a
similar role in central glucose detection (Marty et al., 2005;
Mounien et al., 2010) and in the control by glucose of the para-
sympathetic and sympathetic nervous activities (Tarussio et al.,
2014). Here, we provide evidence for the functional association
of GLUT2 with glucose sensing in neurons. Whole-cell and cell-
attached recordings showed that lowering glucose increased
excitability of GLUT2-expressing neurons, an effect relying on
glucose metabolism and the subsequent closure of leak K+
channels. A mediator of this response is an increase in intracel-
lular AMP/ATP ratio that activates AMP kinase, as shown for
the response of other GI neurons, such as those of the VMH
(Murphy et al., 2009).Cell Metabolism 19, 527–5Membrane depolarization of GI neu-
rons has been attributed to diverse
mechanisms, including the reduction
of Na+/K+ATPase activity (Balfour and
Trapp, 2007), the AMP kinase-dependent
inhibition of the CFTR chloride conduc-
tance (Murphy et al., 2009), or the closure
of leak K+ channels (Balfour and Trapp,
2007; Burdakov et al., 2006). We show
that NTS GLUT2 neurons’ response to
low glucose depends on a leak K+ chan-
nel. However, in contrast to NTS GLUT2
neurons, leak K+ channel-driven gluco-
privic signaling in LH orexin neurons re-
quires not glucose uptake or metabolism,
but a putative cell surface receptor (Gon-
za`lez et al., 2009). Thus, hypoglycemiacan use different signaling pathways to control the same mem-
brane conductances.
An important observation is that depolarization of GLUT2 NTS
neurons increased progressively as external glucose concentra-
tions decreased below euglycemic-like levels (however, within
the physiological extracellular concentration range found in the
brain). Thus, glucose-sensitive GLUT2-expressing neurons are
in a position to fine-tune NTS glucoregulatory responses over
physiological glucose concentrations.
Numerous studies indicated that brainstem and NTS glucose-
responsive neurons are involved in whole-body glucoregulation,
such as neuroglucopenia-induced counterregulation and stimu-
lation of feeding (Briski and Marshall, 2000; Dunn-Meynell et al.,
2009). It was also shown that NTS neurons were connected to
pancreas-projecting DMNX neurons by retrograde labeling using
pseudorabies viruses (Buijs et al., 2001). In addition, NTS stimu-
lation evoked GABAergic synaptic activity in DMNX (Ferreira
et al., 2001). Here, we showed that optogenetic activation of
GABAergic GLUT2 neurons of the NTS led to increased activity
of vagal nerve and glucagon secretion, strongly suggesting
that NTS GLUT2 neurons participate in physiological glucoregu-
latory responses.38, March 4, 2014 ª2014 Elsevier Inc. 535
Figure 6. Optogenetic Stimulation of GLUT2
Neurons
(A) IR-DIC and fluorescence image (EYFP) of a
GLUT2 neuron in the NTS. Scale bar, 10 mm.
(B) Example firing response (current clamp) and
photocurrent (voltage clamp) induced by contin-
uous blue light illumination (473 nm).
(C) Example photocurrents induced by brief pulses
(10 ms) of blue light of increasing frequencies.
(D) Schematic representation of the recording con-
figuration during in vivo optogenetic stimulation.
(E) Vagal firing rate in response to pulsed blue light
stimulation (dotted blue line) in ChR2-expressing
mice and their control littermates.
(F) Blood glucagon levels measured at baseline
and at the end the optogenetic stimulation in both
mouse groups.
Error bars represent SEM.
*p < 0.05; **p < 0.01.
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GLUT2 Neurons Control Glucagon SecretionActivation of parasympathetic nerves by NTS GABA neurons
is consistent, on the one hand, with our observation that NTS
GLUT2 neurons send projections into the DMNX and, on the
other hand, with the demonstration that a sizeable fraction of
the NTS GABAergic input to the DMNX activates vagal nerves
through inhibition of local tonic inhibitory neurons (Babic et al.,
2011). The fact that hypoglycemia-induced parasympathetic ac-
tivity stimulates glucagon secretion is well established (Berthoud
et al., 1990; Patel, 1984). Parasympathetic activity triggers the
initial counterregulatory response to hypoglycemia when blood
glucose concentration falls below euglycemia, whereas activa-
tion of sympathetic activity is triggered at lower glycemic levels
(Taborsky and Mundinger, 2012). In previous studies, we
showed that hypoglycemia or 2-DG-induced neuroglucopenia
induced differential glucagon secretion in control and Glut2 null
mice. Importantly, this differential response was observed at in-
termediate levels of hypoglycemia (2.5 mM) or following injec-
tions of carefully selected doses of 2-DG. At lower glycemic
levels (1 mM) or following injection of larger doses of 2-DG,
glucagon secretion was equally stimulated in control and
knockout mice (Burcelin and Thorens, 2001; Marty et al.,
2005). We thus hypothesized that GLUT2-dependent nervous
glucose sensing was involved in the detection of small, physio-
logical changes in glycemic levels. Our present data showing
that NTS GLUT2 neurons are GI neurons inducing glucagon
secretion through activation of parasympathetic activity are in
agreement with this previous hypothesis. Clear evidence has
now been obtained that glucagon secretion is also controlled
by intrinsic alpha cell glucose sensing (Zhang et al., 2013). The
respective roles of neural and alpha cell glucose sensing in phys-
iological counterregulation still need to be established.
Collectively, our study provides the functional characterization
of a unique class of glucose-sensing neurons based on the
expression of the GLUT2 glucose transporter. They demonstrate
that the NTS is indeed an important site for glucose sensing, in
particular during development of hypoglycemia, that can be
mobilized to induce glucagon secretion. This is an important
step in elucidating not only the mechanisms controlling stimu-
lated glucagon secretion in physiological conditions, but also536 Cell Metabolism 19, 527–538, March 4, 2014 ª2014 Elsevier Inc.when this secretion becomes unresponsive to developing hypo-
glycemia, as associated with hypoglycemia-associated auto-
nomic failure (Cryer, 2006), a serious condition that limits insulin
treatment of both type 1 and type 2 diabetes.
EXPERIMENTAL PROCEDURES
Slice Preparation
Sagittal slices of brainstem, 200 mm thick, containing NTS were cut in ice-cold
extracellular solution with 10 mM glucose using a vibratome and maintained in
an incubation chamber at room temperature until used.
Electrophysiology
Slices were placed in a submerged-type recording chamber and continuously
superfused with extracellular solution at room temperature. tdTomato-
expressing neurons were localized by confocal epifluorescence microscopy.
Whole-cell recordings from visually identified neurons where obtained with
borosilicate glass pipettes. Continuous recordings of Vm were used to monitor
the effect of glucose and drugs. Hyperpolarizing current pulses were periodi-
cally injected to monitor Rinput. Step protocols were used for additional mea-
surements of cell properties. Cell-attached recordings were performed on
slices superfused with an extracellular solution promoting spontaneous firing.
Data Analysis
Electrophysiological data were analyzed with pCLAMP 10 (Molecular
Devices). Voltages were corrected for calculated liquid junction potentials.
Pooled data were presented as mean ± SEM. Statistical analysis and curve
fitting were done with Origin 8.5 (OriginLab). Statistical testing was performed
with paired and unpaired two-tailed Student’s t tests unless stated otherwise.
Differences were considered significant for p < 0.05 (*p < 0.05; **p < 0.01; ***p <
0.001; n.s., nonsignificant).
Single-Cell RT-PCR
The single-cell content was aspirated with a patch pipette and expelled into an
RNase-free PCR tube for reverse transcription. We then performed two suc-
cessive PCR rounds. The first round used the cDNAs present in the reverse
transcription reaction as a template. The second round used 10 ml of the first
PCR product as a template. The products of the second PCR round were
analyzed on agarose gel using ethidium bromide.
Immunohistochemistry
Immunostainings were done on brainstem cryosections obtained from mice
perfused with 4% paraformaldehyde. Sections were incubated with primary
monoclonal antibodies against GAD67 (MAB5406; Chemicon), PV (PV235;
Cell Metabolism
GLUT2 Neurons Control Glucagon SecretionSwant), and pAMPK (ab2535; Cell Signaling Technology) and with an anti-
mouse fluorescein isothiocyanate (FITC)-coupled secondary antibody. To
reveal biocytin-filled neurons, acute slices were fixed with 4% PFA after
recording and incubated with Cascade Blue NeutrAvidin (A2663; Invitrogen).
In addition, immunostaining was performed on these slices with a monoclonal
antibody against choline acetyltransferase (ab35948; Abcam).
Image Acquisition and Processing
Confocal images of immunostained cryosections and acute slices were ob-
tained and processed with ImageJ (Rasband, W.S., NIH, Bethesda, Maryland,
USA) to obtain maximum-intensity projection representations. High-resolution
images were deconvolved with Huygens (Scientific Volume Imaging). In addi-
tion, 3D surface renderings were produced with Imaris (Bitplane).
Optogenetics Experiments
ChR2-expressing neurons were activated with a blue laser (473 nm, 100 mW;
Rapp OptoElectronic) coupled to an optical fiber (200 mm core; Thorlabs). For
slice experiments, the fiber was attached to a micromanipulator and brought
close to the recorded cell. Blue light-induced photocurrents and action poten-
tials were recorded. For in vivo experiments, the fiber was positioned above
the NTS of anesthetized mice with a stereotaxic apparatus. Repetitive trains
of blue light pulses were applied for 40 min. The firing rate of the vagus nerve
was monitored during the stimulation. Blood glucagon levels were dosed by
radioimmunoassay shortly after the end of the stimulation.
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